View More View Less
  • 1 Debreceni Egyetem, Orvos- és Egészségtudományi Centrum, Általános Orvostudományi Kar Belgyógyászati Intézet, Gasztroenterológiai Tanszék Debrecen Nagyerdei krt. 98. 4012
  • 2 Debreceni Egyetem, Orvos- és Egészségtudományi Centrum, Általános Orvostudományi Kar Kórházhigiénés Osztály Debrecen Nagyerdei krt. 98. 4012
  • 3 Debreceni Egyetem, Orvos- és Egészségtudományi Centrum, Általános Orvostudományi Kar Belgyógyászati Intézet, Hematológiai Tanszék Debrecen Nagyerdei krt. 98. 4012
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $1,070.00

A bakteriális infekciók a májcirrhosis jól ismert szövődményei, jelentősen emelik a mortalitást. A májelégtelenség súlyossága és a gastrointestinalis vérzés fontos hajlamosító tényezők. A leggyakoribb fertőzések a spontán bakteriális peritonitis, a húgyúti és légúti fertőzések, valamint a sepsis. A kórokozók között azonos arányban fordulnak elő Gram-negatív és -pozitív baktériumok. Gastrointestinalis vérzés esetén (varix vagy nem varix eredetű) az ascites meglététől vagy hiányától függetlenül rövidtávú profilaktikus antibiotikus kezelés (per os norfloxacin vagy ciprofloxacin) javasolt (primer prevenció) . A kórházi kezelés ideje alatt gastrointestinalis vérzés hiányában is megfontolandó a norfloxacin adása alacsony ascites proteintartalom esetén. A spontán bakteriális peritonitis empirikus kezelésében iv. III. generációs cephalosporin adása javasolt, mely a tenyésztési lelet alapján célzott antibiotikus kezelésre váltható. A kezelés időtartama 5–8 nap. Jó alternatíva lehet az amoxicillin/klavulánsav kombináció, valamint korábban spontán bakteriális peritonitis profilaxisban nem részesülő betegek esetén valamely kinolonszármazék is. Az iv. megkezdett antibiotikus kezelés megfelelő klinikai javulás mellett 2 nap múlva per os kezelésre váltható. Veseelégtelenség társulása esetén kiegészítő albuminkezelés szükséges. Hosszú távú antibiotikum-profilaxis a spontán bakteriális peritonitis epizód lezajlását követően a gyakori kiújulás veszélye miatt minden betegnél indokolt (szekunder prevenció) . A „szelektív intestinalis dekontaminációra” leginkább a per os adott, elsősorban rosszul felszívódó fluorokinolonszármazék, a norfloxacin javasolt. A per os adott ciprofloxacin vagy méginkább a levofloxacin, ez utóbbi Gram-pozitívak ellen is hatékony, megfelelő alternatíva lehet. Trimetoprim/sulfamethoxazole adása csak abban az esetben jön szóba, ha a beteg nem kaphat kinolonszármazékot. A kezelést az ascites eltűnéséig; az ascites perzisztálása esetén a beteg élete végéig vagy a májtranszplantációig kell folytatni. A rezisztens törzsek kialakulásának veszélye miatt hosszútávú profilaxis spontán bakteriális peritonitisen még át nem esett asciteses cirrhosisos betegekben nem javasolt, akkor sem, ha az ascites terápia refrakter, vagy pedig fehérjetartalma alacsony.

  • Borzio, M., Salerno, F., Piantoni, L. és mtsai: Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig. Liver Dis., 2001, 33 , 41–48.

    Piantoni L. , 'Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study ' (2001 ) 33 Dig. Liver Dis. : 41 -48.

    • Search Google Scholar
  • Caly, W. R., Strauss, E.: A prospective study of bacterial infections in patients with cirrhosis. J. Hepatol., 1993, 18 , 353–358.

    Strauss E. , 'A prospective study of bacterial infections in patients with cirrhosis ' (1993 ) 18 J. Hepatol. : 353 -358.

    • Search Google Scholar
  • Deschenes, M., Villeneuve, J. P.: Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis. Am. J. Gastroenterol., 1999, 94 , 2193–2197.

    Villeneuve J. P. , 'Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis ' (1999 ) 94 Am. J. Gastroenterol. : 2193 -2197.

    • Search Google Scholar
  • Goulis, J., Patch, D., Burroughs, A. K.: Bacterial infection in the pathogenesis of variceal bleeding. Lancet, 1999, 353 , 139–142.

    Burroughs A. K. , 'Bacterial infection in the pathogenesis of variceal bleeding ' (1999 ) 353 Lancet : 139 -142.

    • Search Google Scholar
  • Thalheimer, U., Triantos, C. K., Samonakis, D. N. és mtsai: Infection, coagulation, and variceal bleeding in cirrhosis. Gut, 2005, 54 , 556–563.

    Samonakis D. N. , 'Infection, coagulation, and variceal bleeding in cirrhosis ' (2005 ) 54 Gut : 556 -563.

    • Search Google Scholar
  • Benavides, J., Fernandez, N., Colombato, L.: Further evidence linking bacterial infection and upper G. I. bleeding in cirrhosis. Results from a large multicentric prospective survey in Argentina. J. Hepatol., 2003, 38(suppl 2) , A176.

    Colombato L. , 'Further evidence linking bacterial infection and upper G. I. bleeding in cirrhosis. Results from a large multicentric prospective survey in Argentina ' (2003 ) 38 J. Hepatol. : A176 -.

    • Search Google Scholar
  • Bernard, B., Grange, J. D., Khac, E. N. és mtsai: Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology, 1999, 29 , 1655–1661.

    Khac E. N. , 'Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis ' (1999 ) 29 Hepatology : 1655 -1661.

    • Search Google Scholar
  • Papp M., Udvardy M., Vitális Zs. és mtsai: Gastrooesophagealis varixvérzés – Újdonságok a patofiziológia terén gastrooesophagealis varixvérzés, portalis hypertensio, bakteriális infekció, hemosztázis. Orv. Hetil., 2006, 147 , 309–314.

    Vitális Zs. , 'Gastrooesophagealis varixvérzés – Újdonságok a patofiziológia terén gastrooesophagealis varixvérzés, portalis hypertensio, bakteriális infekció, hemosztázis ' (2006 ) 147 Orv. Hetil. : 309 -314.

    • Search Google Scholar
  • Rosa, H., Silverio, A. O., Perini, R. F. és mtsa: Bacterial infection in cirrhotic patients and its relationship with alcohol. Am. J. Gastroenterol., 2000, 95 , 1290–1293.

    Perini R. F. , 'Bacterial infection in cirrhotic patients and its relationship with alcohol ' (2000 ) 95 Am. J. Gastroenterol. : 1290 -1293.

    • Search Google Scholar
  • Campillo, B., Richardet, J. P., Kheo, T. és mtsa: Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection. Clin. Infect. Dis., 2002, 35 , 1–10.

    Kheo T. , 'Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection ' (2002 ) 35 Clin. Infect. Dis. : 1 -10.

    • Search Google Scholar
  • Campillo, B., Dupeyron, C., Richardet, J. P. és mtsai: Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: effect of long-term administration of norfloxacin. Clin. Infect. Dis., 1998, 26 , 1066–1070.

    Richardet J. P. , 'Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: effect of long-term administration of norfloxacin ' (1998 ) 26 Clin. Infect. Dis. : 1066 -1070.

    • Search Google Scholar
  • Bán É., Prinz Gy.: A carbapenemek mikrobiológiai aktivitása, farmakokinetikája és klinikai alkalmazása. LAM, 2000, 10 , 196–205.

    Prinz Gy. , 'A carbapenemek mikrobiológiai aktivitása, farmakokinetikája és klinikai alkalmazása ' (2000 ) 10 LAM : 196 -205.

    • Search Google Scholar
  • Campillo, B., Dupeyron, C., Richardet, J. P.: Epidemiology of hospital-acquired infections in cirrhotic patients: effect of carriage of methicillin-resistant Staphylococcus aureus and influence of previous antibiotic therapy and norfloxacin prophylaxis. Epidemiol. Infect., 2001, 127 , 443–450.

    Richardet J. P. , 'Epidemiology of hospital-acquired infections in cirrhotic patients: effect of carriage of methicillin-resistant Staphylococcus aureus and influence of previous antibiotic therapy and norfloxacin prophylaxis ' (2001 ) 127 Epidemiol. Infect. : 443 -450.

    • Search Google Scholar
  • Husain, S., Tollemar, J., Dominguez, E. A. és mtsai: Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study. Transplantation, 2003, 75 , 2023–2029.

    Dominguez E. A. , 'Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study ' (2003 ) 75 Transplantation : 2023 -2029.

    • Search Google Scholar
  • Ortiz, J., Vila, M. C., Soriano, G. és mtsai: Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients. Hepatology, 1999, 29 , 1064–1069.

    Soriano G. , 'Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients ' (1999 ) 29 Hepatology : 1064 -1069.

    • Search Google Scholar
  • Park, Y. H., Lee, H. C., Song, H. G. és mtsai: Recent increase in antibiotic-resistant microorganisms in patients with spontaneous bacterial peritonitis adversely affects the clinical outcome in Korea. J. Gastroenterol. Hepatol., 2003, 18 , 927–933.

    Song H. G. , 'Recent increase in antibiotic-resistant microorganisms in patients with spontaneous bacterial peritonitis adversely affects the clinical outcome in Korea ' (2003 ) 18 J. Gastroenterol. Hepatol. : 927 -933.

    • Search Google Scholar
  • Garcia-Tsao, G., Wiest, R.: Gut microflora in the pathogenesis of the complications of cirrhosis. Best Pract. Res. Clin. Gastroenterol., 2004, 18 , 353–372.

    Wiest R. , 'Gut microflora in the pathogenesis of the complications of cirrhosis ' (2004 ) 18 Best Pract. Res. Clin. Gastroenterol. : 353 -372.

    • Search Google Scholar
  • Garcia-Tsao, G.: Bacterial infections in cirrhosis. Can. J. Gastroenterol., 2004, 18 , 405–406.

    Garcia-Tsao G. , 'Bacterial infections in cirrhosis ' (2004 ) 18 Can. J. Gastroenterol. : 405 -406.

    • Search Google Scholar
  • Annane, D., Bellissant, E., Cavaillon, J. M.: Septic shock. Lancet, 2005, 365 , 63–78.

    Cavaillon J. M. , 'Septic shock ' (2005 ) 365 Lancet : 63 -78.

  • Wong, F., Bernardi, M., Balk, R. és mtsai: International Ascites Club. Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut, 2005, 54 , 718–725.

    Balk R. , 'International Ascites Club. Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club ' (2005 ) 54 Gut : 718 -725.

    • Search Google Scholar
  • Navasa, M., Rodes, J.: Bacterial infections in cirrhosis. Liver. Int., 2004, 24 , 277–280.

    Rodes J. , 'Bacterial infections in cirrhosis ' (2004 ) 24 Liver. Int. : 277 -280.

  • Strauss, E., Caly, W. R.: Spontaneous bacterial peritonitis: a therapeutic update. Expert Rev Anti Infect Ther., 2006, 4 , 249–60.

    Caly W. R. , 'Spontaneous bacterial peritonitis: a therapeutic update ' (2006 ) 4 Expert Rev Anti Infect Ther. : 249 -60.

    • Search Google Scholar
  • Gines, P., Rimola, A., Planas, R. és mtsai: Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology, 1990, 12 , 716–724.

    Planas R. , 'Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial ' (1990 ) 12 Hepatology : 716 -724.

    • Search Google Scholar
  • Follo, A., Llovet, J. M., Navasa, M. és mtsai: Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology, 1994, 20 , 1495–1501.

    Navasa M. , 'Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis ' (1994 ) 20 Hepatology : 1495 -1501.

    • Search Google Scholar
  • Parsi, M. A., Atreja, A., Zein, N. N.: Spontaneous bacterial peritonitis: recent data on incidence and treatment. Cleve Clin. J. Med., 2004, 71 , 569–576.

    Zein N. N. , 'Spontaneous bacterial peritonitis: recent data on incidence and treatment ' (2004 ) 71 Cleve Clin. J. Med. : 569 -576.

    • Search Google Scholar
  • Rimola, A., Garcia-Tsao, G., Navasa, M. és mtsai: Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J. Hepatol., 2000, 32 , 142–153.

    Navasa M. , 'Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club ' (2000 ) 32 J. Hepatol. : 142 -153.

    • Search Google Scholar
  • Angeloni, S., Nicolini, G., Merli, M. és mtsai: Validation of automated blood cell counter for the determination of polymorphonuclear cell count in the ascitic fluid of cirrhotic patients with or without spontaneous bacterial peritonitis. Am. J. Gastroenterol., 2003, 98 , 1844–1848.

    Merli M. , 'Validation of automated blood cell counter for the determination of polymorphonuclear cell count in the ascitic fluid of cirrhotic patients with or without spontaneous bacterial peritonitis ' (2003 ) 98 Am. J. Gastroenterol. : 1844 -1848.

    • Search Google Scholar
  • Castellote, J., Lopez, C., Gornals, J. és mtsai: Rapid diagnosis of spontaneous bacterial peritonitis by use of reagent strips. Hepatology, 2003, 37 , 893–896.

    Gornals J. , 'Rapid diagnosis of spontaneous bacterial peritonitis by use of reagent strips ' (2003 ) 37 Hepatology : 893 -896.

    • Search Google Scholar
  • Vanbiervliet, G., Rakotoarisoa, C., Filippi, J. és mtsai: Diagnostic accuracy of a rapid urine-screening test (Multistix8SG) in cirrhotic patients with spontaneous bacterial peritonitis. Eur. J. Gastroenterol. Hepatol., 2002, 14 , 1257–1260.

    Filippi J. , 'Diagnostic accuracy of a rapid urine-screening test (Multistix8SG) in cirrhotic patients with spontaneous bacterial peritonitis ' (2002 ) 14 Eur. J. Gastroenterol. Hepatol. : 1257 -1260.

    • Search Google Scholar
  • Runyon, B. A., Canawati, H. N., Akriviadis, E. A.: Optimization of ascitic fluid culture technique. Gastroenterology, 1988, 95 , 1351–1355.

    Akriviadis E. A. , 'Optimization of ascitic fluid culture technique ' (1988 ) 95 Gastroenterology : 1351 -1355.

    • Search Google Scholar
  • Rimola, A., Salmeron, J. M, Clemente, G. és mtsai: Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicentre study. Hepatology, 1995, 21 , 674–679.

    Clemente G. , 'Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicentre study ' (1995 ) 21 Hepatology : 674 -679.

    • Search Google Scholar
  • Runyon, B. A., McHutchison, J. G., Antillon, M. R. és mtsai: Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients. Gastroenterology, 1991, 100 , 1737–1742.

    Antillon M. R. , 'Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients ' (1991 ) 100 Gastroenterology : 1737 -1742.

    • Search Google Scholar
  • Gomez-Jimenez, J., Ribera, E., Gasser, I. és mtsai: Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients. Antimicrob. Agents Chemother., 1993, 37 , 1587–1592.

    Gasser I. , 'Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients ' (1993 ) 37 Antimicrob. Agents Chemother. : 1587 -1592.

    • Search Google Scholar
  • Grange, J. D., Amiot, X., Grange, V. és mtsai: Amoxicillin-clavulanic acid therapy of spontaneous bacterial peritonitis: a prospective study of twenty-seven cases in cirrhotic patients. Hepatology, 1990, 11 , 360–364.

    Grange V. , 'Amoxicillin-clavulanic acid therapy of spontaneous bacterial peritonitis: a prospective study of twenty-seven cases in cirrhotic patients ' (1990 ) 11 Hepatology : 360 -364.

    • Search Google Scholar
  • Ricart, E., Soriano, G., Novella, M. T. és mtsai: Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients. J. Hepatol., 2000, 32 , 596–602.

    Novella M. T. , 'Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients ' (2000 ) 32 J. Hepatol. : 596 -602.

    • Search Google Scholar
  • Navasa, M., Follo, A., Llovet, J. M. és mtsai: Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology, 1996, 111 , 1011–1017.

    Llovet J. M. , 'Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis ' (1996 ) 111 Gastroenterology : 1011 -1017.

    • Search Google Scholar
  • Tuncer, I., Topcu, N., Durmus, A. és mtsai: Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis. Hepatogastroenterology, 2003, 50 , 1426–1430.

    Durmus A. , 'Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis ' (2003 ) 50 Hepatogastroenterology : 1426 -1430.

    • Search Google Scholar
  • Garcia-Tsao, G.: Further evidence against the use of aminoglycosides in cirrhotic patients. Gastroenterology, 1998, 114 , 612–613.

    Garcia-Tsao G. , 'Further evidence against the use of aminoglycosides in cirrhotic patients ' (1998 ) 114 Gastroenterology : 612 -613.

    • Search Google Scholar
  • Hampel, H., Bynum, G. D., Zamora, E. és mtsa: Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis. Am. J. Gastroenterol., 2001, 96 , 2206–2210.

    Zamora E. , 'Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis ' (2001 ) 96 Am. J. Gastroenterol. : 2206 -2210.

    • Search Google Scholar
  • Terg, R., Cobas, S., Fassio, E. és mtsai: Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study. J. Hepatol., 2000, 33 , 564–569.

    Fassio E. , 'Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study ' (2000 ) 33 J. Hepatol. : 564 -569.

    • Search Google Scholar
  • Sort, P., Navasa, M., Arroyo, V. és mtsai: Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N. Engl. J. Med., 1999, 341 , 403–409.

    Arroyo V. , 'Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis ' (1999 ) 341 N. Engl. J. Med. : 403 -409.

    • Search Google Scholar
  • Sorell, W. T., Quigley, E. M., Jin, G. és mtsai: Bacterial translocation in the portal-hypertensive rat: studies in basal conditions and on exposure to hemorrhagic shock. Gastroenterology, 1993, 104 , 1722–1726.

    Jin G. , 'Bacterial translocation in the portal-hypertensive rat: studies in basal conditions and on exposure to hemorrhagic shock ' (1993 ) 104 Gastroenterology : 1722 -1726.

    • Search Google Scholar
  • Rolando, N., Gimson, A., Philpott-Howard, J. és mtsai: Infectious sequelae after endoscopic sclerotherapy of oesophageal varices: role of antibiotic prophylaxis. J. Hepatol., 1993, 18 , 290–294.

    Philpott-Howard J. , 'Infectious sequelae after endoscopic sclerotherapy of oesophageal varices: role of antibiotic prophylaxis ' (1993 ) 18 J. Hepatol. : 290 -294.

    • Search Google Scholar
  • Soares-Weiser, K., Brezis, M., Tur-Kaspa, R.: Antibiotic prophylaxis of bacterial infections in cirrhotic inpatients: a meta-analysis of randomized controlled trials. Scand. J. Gastroenterol., 2003, 38 , 193–200.

    Tur-Kaspa R. , 'Antibiotic prophylaxis of bacterial infections in cirrhotic inpatients: a meta-analysis of randomized controlled trials ' (2003 ) 38 Scand. J. Gastroenterol. : 193 -200.

    • Search Google Scholar
  • Hou, M. C., Lin, H. C., Liu. T. T.: Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology, 2004, 39 , 746–753.

    Liu. T. T. , 'Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial ' (2004 ) 39 Hepatology : 746 -753.

    • Search Google Scholar
  • Grange, J. D., Roulot, D., Pelletier, G. és mtsai: Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patientswith ascites: a double-blind randomized trial. J. Hepatol., 1998, 29 , 430–436.

    Pelletier G. , 'Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patientswith ascites: a double-blind randomized trial ' (1998 ) 29 J. Hepatol. : 430 -436.

    • Search Google Scholar
  • Novella, M., Sola, R., Soriano, G. és mtsai: Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin. Hepatology, 1997, 25 , 532–536.

    Soriano G. , 'Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin ' (1997 ) 25 Hepatology : 532 -536.

    • Search Google Scholar
  • Bauer, T. M., Follo, A., Navasa, M. és mtsai: Daily norfloxacin is more effective than weekly rufloxacin in prevention of spontaneous bacterial peritonitis recurrence. Dig. Dis. Sci., 2002, 47 , 1356–1361.

    Navasa M. , 'Daily norfloxacin is more effective than weekly rufloxacin in prevention of spontaneous bacterial peritonitis recurrence ' (2002 ) 47 Dig. Dis. Sci. : 1356 -1361.

    • Search Google Scholar
  • Singh, N., Gayowski, T., Yu, V. L. és mtsa: Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial. Ann. Intern. Med., 1995, 122 , 595–598.

    Yu V. L. , 'Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial ' (1995 ) 122 Ann. Intern. Med. : 595 -598.

    • Search Google Scholar